Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Cerebral venous sinus thrombosis (CVST ... cerebral infarction, intracranial hypertension, unstable or deteriorating neurological status (Benamer & Bone, 2000; Ekseth et al., ...

The benefit of wearing compression socks is to either reduce swelling or improve venous return (blood circulation),” Dr. Bethany Tennant, a licensed naturopathic physician and certified nutrition ...

Health issues that concern men above the age of 4o the most are related to their energy, stamina, and vitality. Men succumb ...

Objective: To explore the diagnosis of cerebral venous sinus stenosis(CVSS) in idiopathic intracranial hypertension(IIH)，and to evaluate the efficacy and risk of ...

For hundreds of years, people have turned to chocolate to boost heart health. Back in the 1500s, the indigenous Aztec people ...

High blood pressure, stress, sun exposure ... Without treatment, this can lead to venous swelling and potentially life threatening complications. Hormone changes during pregnancy can lead to ...

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

Background Orbital cavernous venous malformations (OCVMs ... as well as low intraoperative diastolic blood pressure. Central retinal artery occlusion was the most common cause of vision loss.

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

Idiopathic Intracranial Hypertension (IIH) is a rare disorder characterized ... Endovascular treatment for venous sinus stenosis, a key contributor to IIH, is an uncommon and complex intervention ...